Please provide your email address to receive an email when new articles are posted on . Lower Schirmer’s test score correlated with increased corneal staining and more severe disease burden among ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the designation of Schirmer test, a measure of tear production, as the sole primary endpoint in ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The reactive ...
Reproxalap Statistically Superior to Vehicle for Both Prespecified Primary Endpoints of Schirmer Test (p=0.0001) and ≥10 mm Schirmer Test Responder Proportions (p<0.0001) TRANQUILITY-2 Results May ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery ...
On the first day, patients received four doses, and Schirmer testing (a measure of tear volume) was performed before and after the fourth dose. On the second day, doses were administered just prior to ...
Please provide your email address to receive an email when new articles are posted on . Botulinum toxin A significantly improved tear breakup time, tear meniscus height and Schirmer test score.
Please provide your email address to receive an email when new articles are posted on . Tanfanercept did not meet the primary efficacy endpoints in a phase 3 trial. A secondary outcome measure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results